Christopher M. Callahan, MD, the founding director of the Indiana University Center for Aging Research and a Regenstrief Institute investigator, will serve as the Society of General Internal Medicine’s Distinguished Professor of Geriatrics at the organization‘s 2018 annual meeting in Denver from April 11 to 14.

Over nearly three decades, Dr. Callahan has developed, tested and implemented new models of care designed to improve the health of older adults. These models facilitate collaboration between patients, their families, healthcare providers and community service agencies with an emphasis on applying health information technology. Both his research and clinical work focus on improving care for individuals with late-life depression and dementia.

“Many older adults fear the prospect of losing their mental capacities more than they fear death,” said Dr. Callahan. “Potential insults to brain health are seemingly everywhere, ranging from conditions like vascular disease and dementia, to conditions like depression and head trauma, to the side effects of medications, to the consequences of inactivity and poor nutrition. We are working to get better in helping older adults protect their brains and building communities that help maintain healthy brains.”

Dr. Callahan is the Cornelius and Yvonne Pettinga Professor of Medicine at IU School of Medicine and the Chief Research and Development Officer of Eskenazi Health, where he also directs the Brain Health Patient Safety Learning Laboratory. He serves as a member of the Board of Directors of the Richard M. Fairbanks Foundation.

Through its Distinguished Professor of Geriatrics program, the Society of General Internal Medicine honors a general internist or geriatrician with nationally recognized expertise in education, research, and/or clinical care related to the care of older adults. The program facilitates career development of society members in academic fields directly related to older patients.

In addition to engaging in scientific and poster sessions with Society of General Internal Medicine meeting participants, Dr. Callahan will deliver the Distinguished Professor of Geriatrics keynote lecture on April 12.

Related News

Jun 24, 2019 • Expert Opinion, News
Can Deprescribing Drugs Linked to Cognitive Impairment Actually Reduce Risk of Dementia?
JAMA Internal Medicine commentary highlights opportunity to discover modifiable risk factors for dementia In a commentary published in JAMA Internal Medicine, three Regenstrief Institute  research scientists write that while they and other researchers have identified a strong and consistent link between anticholinergic drugs and cognitive impairment from observational studies, randomized clinical trials represent the only…
Continue Reading >
Jun 18, 2019 • News
Regenstrief scientist explains how class of drugs may be related to dementia
Regenstrief research scientist Noll Campbell, PharmD, M.S., spoke about a common class of drugs and how it affects the brain on an Indianapolis radio show. Dr. Campbell was a guest on Caregiver Crossing, which airs every Saturday on 93.1 WIBC. Dr. Campbell addressed the topic of anticholinergics and their potential link to Alzheimer’s and dementia.…
Continue Reading >